Department of Health

1. Copies of any correspondence received by the department, from MSD, Pfizer, Eli Lilly, AbbVie, Johnson & Johnson, Novo Nordisk, Novartis, AstraZeneca, Roche, the Irish Pharmaceutical Healthcare Association, European Federation of Pharmaceutical Industries and Associations, related to the EU general pharma legislation/changes to regulatory data protection, competitiveness, between 20th January and 13th June 2025. 2. Minutes of any meetings between department officials and MSD, Pfizer, Eli Lilly, AbbVie, Johnson & Johnson, Novo Nordisk, Novartis, AstraZeneca, Roche, the Irish Pharmaceutical Healthcare Association, European Federation of Pharmaceutical Industries and Associations, related to the EU general pharma legislation/changes to regulatory data protection, between 20th January and 13th June 2025. (To clarify, point 2 for minutes of meetings would also cover meetings attended by the Minister)